Journal of Clinical Medicine Publishes Results of Phase 2 Trial of Nilotinib in Treatment of Dementia with Lewy Bodies
Dementia with lewy bodies (“DLB”) patients, treated with 200mg of nilotinib had statistically significant improvement in cognitive function compared to placebo. MCLEAN, VA, UNITED STATES, June 25, 2025 /EINPresswire.com/ -- Nilotinib …